{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:47:03Z","timestamp":1768823223589,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204507"],"award-info":[{"award-number":["82204507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jpba.2023.115578","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T22:57:55Z","timestamp":1689202675000},"page":"115578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Simultaneous quantification and pharmacokinetics of vincristine and its major metabolite M1 in Chinese pediatric ALL patients by LC-MS\/MS"],"prefix":"10.1016","volume":"234","author":[{"given":"Yawen","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changcheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoling","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115578_bib1","first-page":"185","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 4.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Wierda","year":"2020","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.jpba.2023.115578_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","article-title":"Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review","volume":"84","author":"Madsen","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115578_bib3","first-page":"2416","article-title":"Vincristine-induced peripheral neuropathy in pediatric cancer patients","volume":"6","author":"Mora","year":"2016","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.jpba.2023.115578_bib4","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1002\/cam4.4289","article-title":"The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer","volume":"10","author":"van de Velde","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.jpba.2023.115578_bib5","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.3390\/ijms22084112","article-title":"Vincristine-induced peripheral neuropathy (VIPN) in pediatric tumors: mechanisms, risk factors, strategies of prevention and treatment","volume":"22","author":"Triarico","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2023.115578_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00204-022-03418-8","article-title":"Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts","volume":"97","author":"Wu","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jpba.2023.115578_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08880018.2019.1677832","article-title":"Vincristine-induced peripheral neurotoxicity: a prospective cohort","volume":"37","author":"Nama","year":"2020","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jpba.2023.115578_bib8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/jnci\/djac095","article-title":"Persistence of chemotherapy-induced peripheral neuropathy despite vincristine reduction in childhood B-acute lymphoblastic leukemia","volume":"114","author":"Rodwin","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jpba.2023.115578_bib9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2217\/pgs.14.68","article-title":"Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia","volume":"15","author":"Ceppi","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jpba.2023.115578_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/psp4.12453","article-title":"Physiologically based pharmacokinetic models for adults and children reveal a role of intracellular tubulin binding in vincristine disposition","volume":"8","author":"Lee","year":"2019","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"key":"10.1016\/j.jpba.2023.115578_bib11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1124\/dmd.106.009902","article-title":"Selective metabolism of vincristine in vitro by CYP3A5","volume":"34","author":"Dennison","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2023.115578_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1124\/jpet.106.118471","article-title":"Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes","volume":"321","author":"Dennison","year":"2007","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.jpba.2023.115578_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/17425255.2021.1855141","article-title":"Genetic factors influencing the development of vincristine-induced neurotoxicity","volume":"17","author":"Pozzi","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpba.2023.115578_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cpt.1179","article-title":"Pharmacogenomics of vincristine-induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes","volume":"105","author":"Wright","year":"2019","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.jpba.2023.115578_bib15","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3390\/cancers12071789","article-title":"Population pharmacokinetics of vincristine related to infusion duration and peripheral neuropathy in pediatric oncology patients","volume":"12","author":"van de Velde","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jpba.2023.115578_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1517\/17425255.2014.885016","article-title":"Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies","volume":"10","author":"Said","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpba.2023.115578_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-4347(91)80481-Q","article-title":"Sensitive method for the determination of vincristine in human serum by high-performance liquid chromatography after on-line column-extraction","volume":"572","author":"Bloemhof","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2023.115578_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-4347(00)81078-6","article-title":"Analysis of vinca alkaloids in plasma and urine using high-performance liquid chromatography with electrochemical detection","volume":"424","author":"Vendrig","year":"1988","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2023.115578_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s002800050574","article-title":"Determination of vinca alkaloids in human plasma by liquid chromatography\/atmospheric pressure chemical ionization mass spectrometry","volume":"39","author":"Ram\u00edrez","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115578_bib20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00280-005-0065-9","article-title":"A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer","volume":"57","author":"S.J","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115578_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jchromb.2009.12.015","article-title":"Validation of an electrospray ionization LC\/MS\/MS method for quantitative analysis of vincristine in human plasma samples","volume":"878","author":"Guilhaumou","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2023.115578_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114143","article-title":"Simultaneous quantification of vincristine and its major M1 metabolite from dried blood spot samples of Kenyan pediatric cancer patients by UPLC-MS\/MS","volume":"203","author":"Agu","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115578_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/FTD.0b013e31816b92c9","article-title":"Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography\/tandem mass spectrometry","volume":"30","author":"Dennison","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2023.115578_bib24","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.ejca.2010.03.002","article-title":"Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate","volume":"46","author":"Israels","year":"2010","journal-title":"Eur. J. Cancer (Oxf., Engl.: 1990)"},{"key":"10.1016\/j.jpba.2023.115578_bib25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2141.2008.07235.x","article-title":"Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia","volume":"142","author":"L\u00f6nnerholm","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jpba.2023.115578_bib26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejca.2004.10.006","article-title":"Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG)","volume":"41","author":"Groninger","year":"2005","journal-title":"Eur. J. Cancer (Oxf., Engl.: 1990)"},{"key":"10.1016\/j.jpba.2023.115578_bib27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-3476(94)70027-3","article-title":"Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia","volume":"125","author":"Crom","year":"1994","journal-title":"J. Pedia"},{"key":"10.1016\/j.jpba.2023.115578_bib28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/aps.2012.44","article-title":"Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors","volume":"33","author":"Yan","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpba.2023.115578_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s002800050968","article-title":"Vincristine pharmacokinetics after repetitive dosing in children","volume":"44","author":"Gidding","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115578_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mpo.2950240405","article-title":"Vincristine disposition in children with acute lymphoblastic leukemia","volume":"24","author":"de Graaf","year":"1995","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.jpba.2023.115578_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1203\/00006450-200207000-00021","article-title":"Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia","volume":"52","author":"Groninger","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jpba.2023.115578_bib32","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/jms.1211","article-title":"A sensitive and selective liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer","volume":"42","author":"Lee","year":"2007","journal-title":"J. Mass Spectrom.: JMS"},{"key":"10.1016\/j.jpba.2023.115578_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pbc.21691","article-title":"Vincristine pharmacokinetics in children with Down syndrome","volume":"52","author":"L\u00f6nnerholm","year":"2009","journal-title":"Pediatr. blood Cancer"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:34:55Z","timestamp":1760002495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523003473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"alternative-id":["S0731708523003473"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115578","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification and pharmacokinetics of vincristine and its major metabolite M1 in Chinese pediatric ALL patients by LC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115578"}}